Ulugbek Nizamov

17 works

Republican Specialized Center of Cardiology, Tashkent, Uzbekistan

1. The Relationship between the Parameters of Blood Pressure Variability and Arterial Wall Stiffness in Patients with Arterial Hypertension

   Nigora Tursunova, Ulugbek Nizamov, R. D. Kurbanov +3

   ArticleCardiovascular Health and Disease PreventionInternational Journal of Biomedicine20192 citations

   ABIABI:AkademIndex/openalex/2019.article.000716

2. P403Viable myocardium in patients with left ventricular aneurysm

   E. Shalaeva, Ulugbek Nizamov, A. Shalaeva +1

   ArticleCardiac Structural Anomalies and RepairCardiovascular Research20140 citations

   ABIABI:AkademIndex/openalex/2014.article.000428

3. Study of main arteries stiffness in patients with coronary heart disease depending on prevalence of atherosclerosis

   Ulugbek Nizamov, F.M. Bekmetova, S. KHOSHIMOV +2

   ArticleCardiovascular Health and Disease PreventionCor et Vasa20160 citations

   ABIABI:AkademIndex/openalex/2016.article.000335

4. Ефективна кардіо- та вазопротекція шестимісячною комбінованою терапією індапамідом з амлодипіном і блокатором РААС у хворих з есенціальною гіпертонією високого ризику

   L. Khafisova, Ulugbek Nizamov, Gulnoz Khamidullaeva

   ArticleNausea and vomiting managementHYPERTENSION20170 citations

   ABIABI:AkademIndex/openalex/2017.article.000674

5. P767Efficacy and safety of switching simvastatin intolerant patients with coronary artery disease to rosuvastatin treatment

   Aleksandr B. Shek, Р. Д. Курбанов, G J Abdullaeva +3

   ArticleLipoproteins and Cardiovascular HealthEuropean Heart Journal20170 citations

   ABIABI:AkademIndex/openalex/2017.article.000751

6. Burden of familial heterozygous hypercholesterolemia in Uzbekistan: Time is muscle

   Aleksandr B. Shek, Rano Alieva, R. D. Kurbanov +4

   ArticleLipoproteins and Cardiovascular HealthAtherosclerosis20180 citations

   ABIABI:AkademIndex/openalex/2018.article.000323

7. Personalized rosuvastatin therapy in problem patients with partial statin intolerance

   Aleksandr B. Shek, R. D. Kurbanov, Rano B. Alieva +5

   ArticleLipoproteins and Cardiovascular HealthArchives of Medical Science - Atherosclerotic Diseases20180 citations

   ABIABI:AkademIndex/openalex/2018.article.000387

8. Can metformin stabilize PCSK9 level in stable coronary artery disease patients treated with statins?

   Aleksandr B. Shek, Rano B. Alieva, R. D. Kurbanov +3

   ArticleLipoproteins and Cardiovascular HealthArchives of Medical Science - Atherosclerotic Diseases20190 citations

   ABIABI:AkademIndex/openalex/2019.article.000163

9. Structural Changes Brachiocephalic Arteries In Patients With Chd And Hefh Taking Into Account The Level Of Pcsk9 And Genetic Polymorphism E670G Of The Pcsk9 Gene

   Р Алиева, Aleksandr B. Shek, Р. Д. Курбанов +2

   ArticleCancer, Lipids, and MetabolismAtherosclerosis20190 citations

   ABIABI:AkademIndex/openalex/2019.article.001342

10. Influence of MMP-3 genetic polymorphism on arterial stuffness in patients with coronary heart disease

    Р Алиева, Ulugbek Nizamov, S N Akhmedova +1

    ArticleCardiovascular Health and Disease PreventionAtherosclerosis20200 citations

    ABIABI:AkademIndex/openalex/2020.article.003921

11. TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice

    Krzysztof J. Filipiak‬, Miguel Camafort, Matteo Cameli +9

    ArticleLipoproteins and Cardiovascular HealthCardiology Journal20220 citations

    ABIABI:AkademIndex/openalex/2022.article.001294

12. Gender Differences in 10-Year Mortality in Patients with Coronary Artery Disease with Elevated Lipoprotein(a): In Search of Invisible Guardian Angel

    Aleksandr B. Shek, Rano B. Alieva, А. А. Абдуллаев +5

    ArticleLipoproteins and Cardiovascular HealthInternational Journal of Biomedicine20220 citations

    ABIABI:AkademIndex/openalex/2022.article.005469

13. STRUGGLE FOR. Italian-Polish-Spanish-Uzbek-Vietnamese Expert Forum Position Paper 2023 for better control of classical modifiable risk factors in clinical practice

    Krzysztof J. Filipiak‬, Vivencio Barrios, Claudio Ferri +10

    ArticleBlood Pressure and Hypertension StudiesCardiology Journal20230 citations

    ABIABI:AkademIndex/openalex/2023.article.011615

14. STRUGGLE FOR. Włosko-polsko-hiszpańsko-uzbecko-wietnamskie Stanowisko Ekspertów 2023 dotyczące lepszej kontroli klasycznych modyfikowalnych czynników ryzyka w praktyce klinicznej

    Krzysztof J. Filipiak‬, Vivencio Barrios, Claudio Ferri +10

    ArticleEuropean and International Law StudiesChoroby Serca i Naczyń20230 citations

    ABIABI:AkademIndex/openalex/2023.article.013346

15. Relationship between coronary atherosclerotic lesion and arterial stiffness in patients with coronary artery disease

    D. B. Yusupalieva, Acc Shek, Ulugbek Nizamov

    ArticleBiomarkers in Disease MechanismsEuropean Heart Journal20240 citations

    ABIABI:AkademIndex/openalex/2024.article.008618

16. Comparative analysis of cardiometabolic parameters in patients with coronary heart disease with and without non-alcoholic fatty liver disease

    D. B. Yusupalieva, Р Алиева, Ulugbek Nizamov +4

    ArticleLiver Disease Diagnosis and TreatmentExploration of Cardiology20250 citations

    ABIABI:AkademIndex/openalex/2025.article.005824

17. EASY OR NOT. European-Asian Six countries Yearly consensus On Recent guidelines: arterial hypertension, atrial fibrillation, chronic coronary syndromes, and peripheral artery diseases. Novel Or conventional Treatment options for these patients. Position Paper 2024

    Krzysztof J. Filipiak‬, Matteo Cameli, Santiago J. Freire +9

    Review articleBlood Pressure and Hypertension StudiesCardiology Journal20250 citations

    ABIABI:AkademIndex/openalex/2025.review-article.000204